#United States #Veridian Healthcare #ScarScience #Mitchell-Vance #Gurnee, Illinois

Veridian Healthcare Expands Portfolio with ScarScience Acquisition

In a significant move to bolster its position in the healthcare market, Veridian Healthcare, LLC has successfully completed the acquisition of the ScarScience brand and associated assets from Mitchell-Vance Laboratories, LLC. This strategic acquisition is set to enhance Veridian's offerings in scar care and treatment, further cementing its reputation as a leader in health, wellness, and personal care solutions.

Founded in 2008, Mitchell-Vance Laboratories has garnered extensive experience in scar treatment research and product development. The ScarScience brand is particularly well-known for its innovative family of medical-grade silicone scar sheets and gel serums. Designed specifically to reduce the appearance and texture of scars, these products include self-adhesive silicone scar sheets and topical silicone serums that have gained popularity among healthcare providers and patients alike.

Veridian Healthcare itself was established in 2009 and has made a name for itself in the industry by developing, importing, and distributing a wide range of health, wellness, and personal care products. Their extensive product portfolio encompasses consumer health items, home diagnostics, and remote patient monitoring solutions, allowing them to cater to various markets, including retail, e-commerce, and professional healthcare.

According to Robert Friedberg, the CEO of Veridian, this acquisition significantly strengthens the company’s position in the scar and wound care sector. With the addition of a trusted scar care brand boasting advanced medical-grade silicone technology, Veridian is poised to extend its reach into plastic surgery, dermatology, and physical therapy channels. "Mitchell-Vance's expertise and ScarScience's reputation for quality are a natural fit with Veridian's distribution capabilities," Friedberg stated.

Jessica Rowen, the President of Mitchell-Vance Laboratories, highlighted the exciting future for ScarScience under the umbrella of Veridian's resources. She mentioned that becoming part of Veridian's extensive portfolio opens new opportunities for ScarScience to reach a broader customer base while maintaining the quality and values that existing customers have come to trust.

This acquisition is not just a simple expansion; it represents Veridian's commitment to innovation and quality in healthcare products. By integrating ScarScience into their portfolio, Veridian is enhancing its ability to offer effective solutions for scar treatment, further proving its dedication to improving patient outcomes.

As the healthcare landscape continues to evolve, partnerships and acquisitions such as this will be crucial in providing comprehensive and effective care solutions. Veridian Healthcare, with its proven track record and now bolstered by the ScarScience brand, is well-positioned to lead in this competitive market.

For more information on ScarScience and Veridian Healthcare, interested parties can visit ScarScienceUSA.com and VeridianHealthcare.com. This acquisition marks a new chapter for both companies, aiming to make a significant impact in the field of scar treatment and beyond.